Lam Research Corporation | Large-cap | Technology

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 5.2B
Gross Profit 2.6B 50.08%
Operating Income 1.7B 33.67%
Net Income 1.7B 33.26%

Balance Sheet Metrics

Total Assets 21.3B
Total Liabilities 11.5B
Shareholders Equity 9.9B
Debt to Equity 1.16

Cash Flow Metrics

Operating Cash Flow 1.8B
Free Cash Flow 2.4B

Revenue & Profitability Trend

Lam Research Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i18.4B14.9B17.4B17.2B14.6B
Cost of Goods Sold i9.5B7.9B9.7B9.4B7.8B
Gross Profit i9.0B7.1B7.8B7.9B6.8B
Gross Margin % i48.7%47.3%44.6%45.7%46.5%
Operating Expenses
Research & Development i2.1B1.9B1.7B1.6B1.5B
Selling, General & Administrative i981.7M868.2M832.8M885.7M829.9M
Other Operating Expenses i-----
Total Operating Expenses i3.1B2.8B2.6B2.5B2.3B
Operating Income i5.9B4.3B5.2B5.4B4.5B
Operating Margin % i32.0%28.7%29.9%31.2%30.6%
Non-Operating Items
Interest Income i231.3M251.9M139.0M15.2M19.7M
Interest Expense i178.2M185.2M186.5M184.8M208.6M
Other Non-Operating Income4.0M11.4M-60.3M-19.2M77.7M
Pre-tax Income i6.0B4.4B5.1B5.2B4.4B
Income Tax i599.9M532.4M598.3M587.8M462.3M
Effective Tax Rate % i10.1%12.2%11.7%11.3%10.6%
Net Income i5.4B3.8B4.5B4.6B3.9B
Net Margin % i29.1%25.7%25.9%26.7%26.7%
Key Metrics
EBITDA i6.5B4.9B5.7B5.8B4.8B
EPS (Basic) i$4.17$2.91$3.33$3.29$2.72
EPS (Diluted) i$4.15$2.90$3.32$3.28$2.69
Basic Shares Outstanding i12861010001314100000135472000013989900001436090000
Diluted Shares Outstanding i12861010001314100000135472000013989900001436090000

Income Statement Trend

Lam Research Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i6.4B5.8B5.3B3.5B4.4B
Short-term Investments i--37.6M135.7M1.3B
Accounts Receivable i3.4B2.5B2.8B4.3B3.0B
Inventory i4.3B4.2B4.8B4.0B2.7B
Other Current Assets440.3M298.2M251.8M347.4M207.5M
Total Current Assets i14.5B12.9B13.2B12.3B11.7B
Non-Current Assets
Property, Plant & Equipment i23.2M24.5M53.7M42.2M44.1M
Goodwill i3.4B3.4B3.4B3.1B3.1B
Intangible Assets i182.2M138.5M168.5M101.8M132.4M
Long-term Investments-----
Other Non-Current Assets2.6B1.9B1.9B1.6B1.3B
Total Non-Current Assets i6.8B5.9B5.6B4.9B4.2B
Total Assets i21.3B18.7B18.8B17.2B15.9B
Liabilities
Current Liabilities
Accounts Payable i854.2M614.0M470.7M1.0B829.7M
Short-term Debt i754.3M504.8M8.4M7.4M11.3M
Current Portion of Long-term Debt-----
Other Current Liabilities693.8M609.5M580.6M589.7M456.9M
Total Current Liabilities i6.6B4.3B4.2B4.6B3.5B
Non-Current Liabilities
Long-term Debt i3.7B4.5B5.0B5.0B5.0B
Deferred Tax Liabilities i-----
Other Non-Current Liabilities581.6M575.0M501.3M422.9M398.7M
Total Non-Current Liabilities i4.9B5.9B6.4B6.4B6.3B
Total Liabilities i11.5B10.2B10.6B10.9B9.9B
Equity
Common Stock i1.3M130.0K133.0K137.0K143.0K
Retained Earnings i29.0B24.8B22.0B18.5B14.7B
Treasury Stock i27.8B24.4B21.5B19.5B15.6B
Other Equity-----
Total Shareholders Equity i9.9B8.5B8.2B6.3B6.0B
Key Metrics
Total Debt i4.5B5.0B5.0B5.0B5.0B
Working Capital i7.9B8.5B9.0B7.7B8.1B

Balance Sheet Composition

Lam Research Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i5.4B3.8B4.5B4.6B3.9B
Depreciation & Amortization i386.3M359.7M342.4M333.7M307.2M
Stock-Based Compensation i343.4M293.1M286.6M259.1M220.2M
Working Capital Changes i320.3M680.7M131.6M-1.9B-1.0B
Operating Cash Flow i6.1B5.0B5.2B3.0B3.2B
Investing Activities
Capital Expenditures i-----
Acquisitions i00-120.0M00
Investment Purchases i-00-567.8M-3.4B
Investment Sales i037.8M98.1M1.7B3.9B
Investing Cash Flow i51.1M26.1M-33.0M1.2B422.4M
Financing Activities
Share Repurchases i-3.4B-2.8B-2.0B-3.9B-2.7B
Dividends Paid i-1.1B-1.0B-907.9M-815.3M-727.0M
Debt Issuance i---00
Debt Repayment i-507.5M-256.1M-23.2M-11.9M-862.1M
Financing Cash Flow i-5.1B-4.1B-2.9B-4.7B-4.3B
Free Cash Flow i5.4B4.3B4.7B2.6B3.2B
Net Change in Cash i1.0B882.7M2.2B-499.5M-604.4M

Cash Flow Trend

Lam Research Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 23.82
Forward P/E 23.15
Price to Book 12.72
Price to Sales 6.79
PEG Ratio 23.15

Profitability Ratios

Profit Margin 29.07%
Operating Margin 33.67%
Return on Equity 58.24%
Return on Assets 18.40%

Financial Health

Current Ratio 2.21
Debt to Equity 48.23
Beta 1.66

Per Share Data

EPS (TTM) $4.15
Book Value per Share $7.77
Revenue per Share $14.33

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
lrcx125.1B23.8212.7258.24%29.07%48.23
Applied Materials 131.7B19.596.7235.63%23.88%32.11
KLA 115.6B28.8224.65100.78%33.41%129.75
Teradyne 17.6B38.416.2116.85%16.59%2.62
Entegris 11.9B40.213.128.08%9.17%106.49
Nova 7.3B33.886.6924.23%29.10%19.08

Financial data is updated regularly. All figures are in the company's reporting currency.